NPI Details
DR. Mark Jon Pamer, D.O. is a pulmonary disease internal medicine in Port Saint Lucie, FL with 24 years of experience. The provider is an internist who treats diseases of the lungs and airways. The pulmonologist diagnoses and treats cancer, pneumonia, pleurisy, asthma, occupational and environmental diseases, bronchitis, sleep disorders, emphysema and other complex disorders of the lungs. DR. Mark Jon Pamer, D.O. NPI is 1184824542. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: NOVA SOUTHEASTERN COLLEGE OF OSTEO MEDICINE
Graduation Year:2002
The provider's business location address is:
537 NW LAKE WHITNEY PL STE 103
PORT SAINT LUCIE, FL
ZIP 34986-620
Phone: (772) 785-5864
Fax: (772) 344-2555
The NPI 1184824542 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The CLIA number assigned to this NPI record is 10D1101009 - physician office with a certificate type of Certificate for Provider-Performed Microscopy Procedures (PPMP).
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Injection, tezepelumab-ekko, 1 mg (HCPCS:J2356)
- Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
- Injection, denosumab, 1 mg (HCPCS:J0897)
- Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
- Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS:94060)
- Test to examine how well the lungs exchange gases (HCPCS:94729)
- Test to determine lung volumes using sensors (HCPCS:94726)
- Outpatient heart rehabilitation, qualified health care professional services (HCPCS:93797)
- Professional services for outpatient pulmonary rehabilitation with continuous monitoring of blood oxygen, per session (HCPCS:94626)
- Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
- New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
- Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
- Injection of drug or substance under skin or into muscle (HCPCS:96372)
- Test to measure the level of nitric oxide gas (HCPCS:95012)
- Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
- Test for exercise-induced heart and lung stress (HCPCS:94621)
- Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
- Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
- Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
- Injection of additional new drug or substance into vein (HCPCS:96375)
- Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)
- Adm sarscov2 30mcg/0.3ml bst (HCPCS:0004A)
- Treatment of swallowing and feeding disorder (HCPCS:92526)
- Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
- Treatment of speech, language, voice, communication, and/or hearing processing disorder (HCPCS:92507)
- Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
- Ultrasound of heart with color-depicted blood flow, rate, direction and valve function (HCPCS:93306)
- Fee covid-19 vac 13 res (HCPCS:0124A)
- Coronavirus vaccine 13 (HCPCS:91312)
- Evaluation of use of breathing device (HCPCS:94664)
- New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
- Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use (HCPCS:91301)
- Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
- Analysis of voice and resonance production (HCPCS:92524)
- Unclassified drugs (HCPCS:J3490)
- Study of voice box function (HCPCS:92520)
- Fee covid-19 vac 14 res (HCPCS:0134A)
- Coronavirus vaccine 14 (HCPCS:91313)
- Critical care, first 30-74 minutes (HCPCS:99291)
- Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
- Evaluation and recording of swallowing using an endoscope (HCPCS:92612)
The enumeration date for this NPI number is 7/23/2007 and was last updated on 10/17/2025.
Taxonomy Codes
The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:
| No. |
Taxonomy Code |
Taxonomy Clasification |
Taxonomy Specialization |
License Number |
License State |
Primary |
| 1 | 207RC0200X | Internal Medicine | Critical Care Medicine | T4814 | TEXAS | No |
| 2 | 207RP1001X | Internal Medicine | Pulmonary Disease | OS9475 | FLORIDA | Yes |
| 3 | 207RC0200X | Internal Medicine | Critical Care Medicine | OS9475 | FLORIDA | No |
| 4 | 207RP1001X | Internal Medicine | Pulmonary Disease | T4814 | TEXAS | No |